Rate My Professor Claus Roehrborn

His research specializations include benign prostatic hyperplasia, lower urinary tract symptoms in men, prostate cancer, tumor markers, outcomes research, and urological ultrasound. Roehrborn has contributed to American Urological Association guidelines on LUTS/BPH assessment and treatment since 1994 and produced key publications such as "WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm³ and 80-150-cm³ prostates" (2024), "Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia" (2024), "Three-year outcomes after Aquablation therapy compared to TURP" (2020), "Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline" (2018), and "Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results" (2019). Awards include the Eugene Fuller Triennial Prostate Award (2022), Patricia and William L. Watson, Jr., M.D. Award for Excellence in Clinical Medicine (2010), D Magazine Best Doctor (2010–2022), and Texas Super Doctor (2004–2020). He initiated UT Southwestern's robotic surgery program in 2006 and has lectured as invited visiting professor in over 30 countries.